Liermann, J., Munter, M., Naumann, P., Abdollahi, A., Krempien, R., & Debus, J. (2022). Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial. Clinical and translational radiation oncology, 34, . https://doi.org/10.1016/j.ctro.2022.03.003
Chicago-Zitierstil (17. Ausg.)Liermann, Jakob, Marc Munter, Patrick Naumann, Amir Abdollahi, Robert Krempien, und Jürgen Debus. "Cetuximab, Gemcitabine and Radiotherapy in Locally Advanced Pancreatic Cancer: Long-term Results of the Randomized Controlled Phase II PARC Trial." Clinical and Translational Radiation Oncology 34 (2022). https://doi.org/10.1016/j.ctro.2022.03.003.
MLA-Zitierstil (9. Ausg.)Liermann, Jakob, et al. "Cetuximab, Gemcitabine and Radiotherapy in Locally Advanced Pancreatic Cancer: Long-term Results of the Randomized Controlled Phase II PARC Trial." Clinical and Translational Radiation Oncology, vol. 34, 2022, https://doi.org/10.1016/j.ctro.2022.03.003.